Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Aside from the FDA situation, my biggest concern is that management is receiving too much compensation (they should slow it down for a little while IMHO). The good thing is however a lot of it is cash-based so while it does effect free cash flow, it doesn't dilute the shareholder value.
I like the way how revenues are increasing Y-o-Y and Q-o-Q.
Thanks for the link!
Interesting read. While compensation is high,revenue for the most part has improved. (Research) trials are moving along as well (interestingly, ironically and oddly enough, the FDA likes the way one of their research trials is coming along).
IIRC, the number of approximate shareholders are only 475 - that bodes well if the stock can get some "traction".
I guess in the end it will depend on the FDA case.
Thanks for the short summary!
I'm all up for it!
Yes they use enzyme(s) to remove the stem cells however that potentially (but not necessarily) changes/alters the stem cells viability/characteristics/etc. Many enzymes act as "catalysts" to a reaction and sometimes they do that by changing the configuration/conformation of the the cells chemical properties.
I think that is what the FDA's "gripe" is about.
Regardless, as you mentioned we agree that the FDA's position is untenable-so its all good!
Its a little more complicated than that. The FDA's view is that "washing and bathing" the stem cells in a (chemical) solution alters its properties-hence its no longer "just a person's own cell" and its a drug which needs to be regulated. To me that's really stretching the definition of what a "drug" is.
Also, there is no reason it needs to be overly-regulated by the FDA. Good oversight? Yes, over-regulation? NO!
IMHO this will eventually settle in mediation.
Disclosure: Long USRM.
Maybe EEGI was/is a scam however its made some people a good amount of money over the years.
IMHO, I think it is different this time around. We'll see.
Its fun to speculate.
Absolutely agree !
SHRK went up to 88 cents and you say that's "even worse"?? I'm amused and bemused by that comment. As has been incessantly stated here, pink sheet stocks are NOT long-term hold stocks.
I wish I can share your enthusiasm regarding this stock.
That's been my concern as well - even more than the legal situation which IMHO will resolve positively.
I have a lot of shares so I'm biased and hopefully USRM will prevail. I don't think stem cell therapy will be putting any pharmaceutical companies out of business anytime soon. Stem cell therapy will be one of many useful tools in a physicians toolbox however.
What "debacle"?
Who cares, SHRK went up to 88 cents! These OTC BB stocks are not Pfizer, etc. to hold in a retirement account or "long-term" holding. They are to trade and make a profit. Some people really shouldn't be here.
Regards.
Yup, I agree. While I wish/hope EEGI goes through the roof, I'm certainly not worried about it if it really doesn't do too much. A small move (up) will be highly profitable for me. IMHO Steve will (eventually) do "enough" to make this stock move up a little.
Anyone who thinks these penny/sub-penny stocks are "buy and hold" need to reevaluate their investment strategies.
Cheers
If this "scam" goes up like SHRK remotely did, I'll be doing quite well.
I think all of us (at least most of us) here know these penny/sub-penny stocks are "crap-shoots".
Agreeably, most of these stocks do not pan out however some do. For me fortunately, I'm so far up on EEGI that if I lose 100% of my current EEGI "investment", I'll still be up multi-thousand percent (no typo) on this stock-what am I to complain about?
Cheers.
With no news out in a while, maybe its best not to purchase any shares (IMHO).
Wait a minute there - according to some here USRM doesn't have or come out with any real scientific publications. How can this be?
From what I remember they can't however I'm not 100% sure. Also, there are other regulatory authorities in other countries (and/or EU). That being said, from my readings, ostensibly, other countries treat stem cell therapy more favorably than the USA/FDA does.
Wouldn't be surprised if it goes even lower than that. I'm probably not going to be adding to my position anymore.
Stock isn't however.
I think that's probably my bigger concern for USRM - dilution as well as too much cash/salary executive compensation-it takes from free cash flow.
IMHO, as long as USRM can keep growing revenues I think it will be fine.
Though a trial is scheduled for next year, there is (still) and always the possibility that the case could be resolved outside a court of law.
Many complex cases are resolved out of court and I don't see anything different with this one.
I emailed Steve Smith yesterday morning however I still haven't received a reply yet. Could be he's busy, out of town, vacation, etc. Not really sure.
Regardless of situation, I'll hold my shares and will wait to see what happens. EEGI usually has some kind of (multiple) run(s).
This time around, I'm hoping Ms. Smith someway, somehow makes EEGI a viable business. We'll see. Time will tell.
Yes.
That's why I'm here as well.
Some people believe this company is a sham and management is looking at jail time while others here believe this company has the potential to do very well and are investing as such. Personally, I'm of the latter.
We'll see.
What are these then?
http://us-stemcell.com/clinical-trials/
That is for the judge to decide. The process can be changed/adjusted as well if needed.
You stated: " If enzyme digestion is required, then it’s a drug" - that is incorrect. "Enzyme digestion" is rather a vague term. In fact, "enzyme digestion" is used in food and supplement preparations as well. Being labeled a "drug" would require what specific type of enzyme is used, what is the ("digestion") process and what is the end result (product).
Me too but this company is practically defunct. Not sure what's there to trade anymore.
False signal....LOL!
You might mean this?
I got your sarcasm.
Regardless, to be honest I really don't know if this will gain however given the profits on this stock and given my current position, I'm not really going to complain.
Yes, I'm certainly hoping this stock does well however I've got better things to do than to fret over this stock/company. If it does well then good, if not...time to move on.
Cheers.
Good news is I'm up a couple thousand % on this stock the past number of years so I can wait for it to (hopefully) do something. We'll see.
I certainly hope you are right on the call as I'm sitting on tens of thousands of shares however I will stand by my position that we won't be seeing movement until my aforementioned comments are true.
At the very least, this FDA issue needs to be resolved. I like your optimism however most of the time, the law stands with the FDA. Its a very high hill (maybe not a mountain) for USRM to climb.
IMHO, stem cell therapy is just one of many "future of medicine" concepts. Gene therapy, individualized medicine will be just as important.
We'll only see "dollar land" if things go well for USRM. That includes but is not limited to the FDA situation as well as revenues, earnings, etc.
I'm optimistic and holding my shares. For me, the rewards far outweigh the risks.
Of course, everyone should do their own DD and make their own investment decisions.
Cheers.
I would've been happy with 85 cents as well.
Sure, however you fail to mention that SHRK hit 85 cents first.